POSC206 How Gene Therapy for Rare Diseases Differs from Chronic Therapy: The Case of AADC-Deficiency

Abstract

To characterize the economic differences of Advanced Therapy Medicinal Products (ATMP) therapies versus chronic therapies using the ultra-rare neuropediatric disease Aromatic l-amino acid decarboxylase-deficiency (AADC-d) as an example.